KWKatherine Lisa Whitcroft

Katherine Lisa Whitcroft

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Katherine Lisa Whitcroft has a total of 248 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Vitamin A-Containing Intranasal Drops Improve Odour Detection Threshold

    by Katherine L. Whitcroft, Melanie E. Dietz, Antje Haehner, Thomas Hummel

    Introduction: Retinoic acid, a metabolite of vitamin A (VA), has been shown in animal work to support olfactory receptor neuron regeneration. A limited amount of clinical research has also demonstrated potential therapeutic benefit in patients with olfactory dysfunction (OD). We therefore performed, to our knowledge, the first prospective study investigating whether the intranasal VA-containing “Coldastop” is beneficial in treating patients with non-sinonasal OD. Methods: A non-blinded prospective comparative study was performed, in patients with OD due to post-infectious, post-traumatic, and idiopathic aetiologies. Patients were treated with olfactory training (OT) alone, OT plus intranasal VA (Coldastop, OT+VA), or OT plus intranasal steroids (mometasone furoate, OT+S) for 12 weeks. Full psychophysical olfactory testing was performed before and after treatment using the “Sniffin’ Sticks” test battery (with results for odour threshold, discrimination, identification, and composite “TDI”). Results: A total of 144 patients completed the study: 52 OT, 42 OT+S, 50 OT+VA. The majority of patients had post-infective OD. There were no significant differences between groups in age/sex. There were statistically significant improvements in each subtest (T/D/I) and composite scores (TDI) within each treatment regimen. Across groups, there was a significant interaction between treatment and time (controlling for baseline characteristics) for odour threshold, F(2, 139) = 3.2, p = 0.044, with the largest improvement being seen in the OT+VA group. Further, the greatest proportion of patients reached clinically significant improvement within the OT+VA group (T/D/I/TDI), but this did not reach statistical significance. Conclusion: Intranasal VA may be of benefit in treating OD. Further large-scale randomised trials are required.

  • Open Access

    The Development and Validation of the Smell‐Qx Questionnaire, Based on a Systematic Review of the Literature and the COMET Initiative on the Development of Core Outcome Sets for Clinical Trials in Olfactory Disorders

    by Matt Lechner, Alexander Fjaeldstad, Umar Rehman, Jacklyn Liu, David Boniface, Jim Boardman, Duncan Boak, Aytug Altundag, Johannes Frasnelli, Simon Gane, et al.

    Background: Olfactory dysfunction affects up to 22% of the population. Accurate assessment is vital for diagnosis and tracking outcomes, often using patient‐reported outcome measures (PROMs).Aims: We aimed to develop and validate a novel questionnaire for assessing olfactory and gustatory dysfunction.Methods: A systematic review identified existing smell and taste questionnaires, followed by item generation and selection. After two Delphi cycles and consultation with a large panel of smell and taste experts, the Smell‐Qx questionnaire was developed. A validation study recruited patients from smell and taste clinics (cases) and general ENT clinics (controls) to complete the Smell‐Qx. Additionally, patients with smell and taste disorders underwent psychophysical testing using Sniffin’ Stick Threshold, Discrimination, and Identification (TDI) tests.Results: The Smell‐Qx is an 11‐domain instrument, with five core domains used for total score calculation and six history/quality‐of‐life domains for obtaining a comprehensive history. The validation study recruited 60 participants (32 patients with smell/taste disorders and 28 controls). Items showed acceptable to significant internal consistency (Cronbach's α: 0.64–0.97) and test–retest reliability (ICC: 0.65–0.99, p < 0.001). The Smell‐Qx was effective at distinguishing patients with smell and taste disorders from controls (t = 9.99, df = 58, p < 0.0001). Concurrent criterion validity was good with overall SATD‐related quality of life (r = 0.43, p = 0.015), as well as with the smell loss domain and overall smell TDI scores (r = −0.54, p = 0.011).Conclusion: The Smell‐Qx is a reliable and valid PROM for assessing olfactory and self‐reported gustatory disorders, capturing symptom severity and quality‐of‐life impact. It can integrate into a multi‐modal assessment approach alongside psychophysical testing.


  • Open Access

    Correction: A novel olfactory sorting task

    by Shubin Li, Anne Wolter, Christine Kelly, Barry Smith, Katie Whitcroft, Harry Sherwood, Beth Longley, Thomas Hummel

  • Open Access

    A novel olfactory sorting task

    by Shubin Li, Anne Wolter, Christine Kelly, Barry Smith, Katie Whitcroft, Harry Sherwood, Beth Longley, Thomas Hummel

    Background: This study aimed to develop a simple self-administered screening tool for odor memory, which allowed users to self-test their olfactory function repeatedly even at home. Methods: One hundred and ten participants were recruited (30 men, age = 50.1 ± 9.9 years; 80 women, age = 47.1 ± 11.5 years); half of them were heathy volunteers, the other half were patients with olfactory dysfunction. Fifty-one healthy participants volunteered for a retest within an interval of a maximum of 14 days. Olfactory function was assessed using the extended Sniffin’ Sticks test (SST) comprising tests for odor threshold, identification, and discrimination. All participants received the Novel Olfactory Sorting Task (NOST) which is based on the sorting of 12 matching pairs of odors involving olfactory and cognitive functions. After that, all participants rated questions related to their test performance and the practicability of the test. Results: Consistent with the previous literature, significant effects of age were found. Results showed an acceptable test-retest reliability and a satisfactory validity of the NOST. The NOST score not only had positive correlations with SST, but also was capable of differentiating severe hyposmia/anosmia from normosmia by the score of 5.5 (sensitivity of 76.2%, specificity of 77.6%). Conclusion: The present study showed the good reliability, validity, and possible clinical usefulness of the NOST. As a self-performed screening test, it can be comprehended and conducted easily, which may provide a quick and simple approach to obtaining a global estimation of olfactory and cognitive functions.


  • Open Access

    Patient Experience and Preferences for the Assessment of Olfaction: The Patient International Clinical Assessment of Smell Survey

    by Katherine L. Whitcroft, Christine Kelly, Peter Andrews

    Introduction: Olfactory dysfunction (OD) is common and carries significant personal and societal burden of disease. Accurate assessment of olfaction is required for good clinical care and affords patients insight into their condition. However, the accuracy of assessment varies with technique used, and there is presently little standardisation of clinical practice. We therefore aimed to determine experience of and preferences for olfactory assessment in healthcare-seeking adults. Methods: An anonymous patient co-produced survey was developed in collaboration with a UK-based OD charity. Distribution was via their social media patient forum. “Healthcare seeking” adults (i.e., who had undergone olfactory assessment by a healthcare professional [any care level/speciality] or may do so in the future) were included. Results: 576 people (88.5% female, mean 46 years) responded. Hyposmia, parosmia, and retronasal OD were most frequently reported. 55.2% had been assessed by a healthcare professional – GP most commonly, followed by ENT. Importantly, only 15.6% and 16.9% of respondents had undergone systematic assessment with smell tests or symptom questionnaires, respectively. Most respondents had not undergone imaging. Mean satisfaction was higher in those seen by ENT. Interestingly, respondents prioritise orthonasal odour identification over other forms of smell test. Unfortunately, many felt that healthcare professionals (across specialities) were dismissive towards OD and lacked appropriate knowledge of both its pathophysiology and effects. We propose simple steps that can be taken to improve olfactory assessment, including education and establishment of robust referral networks. Conclusion: We hope these results and supporting practical recommendations will inform future service planning, funding allocation and research, as well as better aligning patient and clinician priorities.


  • Open Access

    International clinical assessment of smell: An international, cross‐sectional survey of current practice in the assessment of olfaction

    by Katherine L. Whitcroft, Isam Alobid, Aytug Altundag, Peter Andrews, Sean Carrie, Miriam Fahmy, Alexander W. Fjældstad, Simon Gane, Claire Hopkins, Julien Wen Hsieh, et al.

    Objectives: Olfactory dysfunction (OD) is common and carries significant personal and societal burden. Accurate assessment is necessary for good clinical and research practice but is highly dependent on the assessment technique used. Current practice with regards to UK/international clinical assessment is unknown. We aimed to capture current clinical practice, with reference to contemporaneously available guidelines. We further aimed to compare UK to international practice.Design: Anonymous online questionnaire with cross‐sectional non‐probability sampling. Subgroup analysis according to subspeciality training in rhinology (‘rhinologists’ and ‘non‐rhinologists’) was performed, with geographical comparisons only made according to subgroup.Participants: ENT surgeons who assess olfaction.Results: Responses were received from 465 clinicians (217 from UK and 17 countries total). Country‐specific response rate varied, with the lowest rate being obtained from Japan (1.4%) and highest from Greece (72.5%). Most UK clinicians do not perform psychophysical smell testing during any of the presented clinical scenarios—though rhinologists did so more often than non‐rhinologists. The most frequent barriers to testing related to service provision (e.g., time/funding limitations). Whilst there was variability in practice, in general, international respondents performed psychophysical testing more frequently than those from the UK. Approximately 3/4 of all respondents said they would like to receive training in psychophysical smell testing. Patient reported outcome measures were infrequently used in the UK/internationally. More UK respondents performed diagnostic MRI scanning than international respondents.Conclusions: To our knowledge, this is the most comprehensive UK‐based, and only international survey of clinical practice in the assessment of OD. We present recommendations to improve practice, including increased education and funding for psychophysical smell testing. We hope this will promote accurate and reliable olfactory assessment, as is the accepted standard in other sensory systems.


  • Open Access

    Orthonasal and retronasal odor identification in patients with parosmia

    by Shubin Li, Paolo Boscolo-Rizzo, Francesco Uderzo, Giancarlo Tirelli, Katherine L. Whitcroft, Thomas Hummel

    Objective: To compare retronasal and orthonasal perception in parosmic COVID-19 patients, in order to determine whether COVID-19 has a differential effect on these functions. Methods: Using the Sniffin Sticks test battery orthonasal function was examined for odor threshold, discrimination and identification. Retronasal function was assessed using 20 tasteless aromatized powders. Gustatory function was measured using the Taste Strips test. Results: This study included 177 patients (127 women, 50 men; mean age 45 years), of whom 127 (72%) were hyposmic and 50 (28%) normosmic. Compared to patients without parosmia, parosmic patients performed worse in odor identification for both orthonasal (F = 4.94, p = 0.03) and retronasal tests (F = 11.95, p < 0.01). However, an interaction effect between route of odor identification (orthonasal or retronasal) and parosmia status was found (F = 4.67, p = 0.03): patients with parosmia had relatively lower retronasal scores than patients without parosmia. Conclusion: Our results suggest that COVID-19 may affect the olfactory mucosa differently along the anterior–posterior axis, thereby possibly contributing to the pathophysiology of parosmia. Patients with parosmia also exhibit a higher degree of impairment when odors are presented through the retronasal route during eating and drinking.


  • Open Access

    Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination

    by Anna Kristina Hernandez, Basile N. Landis, Aytug Altundag, Alexander Wieck Fjaeldstad, Simon Gane, Eric H Holbrook, Caroline Huart, Iordanis Konstantinidis, Matt Lechner, Alberto Macchi, et al.

    Background: Definitions are essential for effective communication and discourse, particularly in science. They allow the shared understanding of a thought or idea, generalization of knowledge, and comparison across scientific investigation. The current terms describing olfactory dysfunction are vague and overlapping. Summary: As a group of clinical olfactory researchers, we propose the standardization of the terms “dysosmia,” “anosmia,” “hyposmia,” “normosmia,” “hyperosmia,” “olfactory intolerance,” “parosmia,” and “phantosmia” (or “olfactory hallucination”) in olfaction-related communication, with specific definitions in this text. Key Messages: The words included in this paper were determined as those which are most frequently used in the context of olfactory function and dysfunction, in both clinical and research settings. Despite widespread use in publications, however, there still exists some disagreement in the literature regarding the definitions of terms related to olfaction. Multiple overlapping and imprecise terms that are currently in use are confusing and hinder clarity and universal understanding of these concepts. There is a pressing need to have a unified agreement on the definitions of these olfactory terms by researchers working in the field of chemosensory sciences. With the increased interest in olfaction, precise use of these terms will improve the ability to integrate and advance knowledge in this field.


  • Open Access

    Functional septorhinoplasty alters brain structure and function: Neuroanatomical correlates of olfactory dysfunction

    by Katherine L. Whitcroft, Laura Mancini, Tarek Yousry, Thomas Hummel, Peter J. Andrews

    Introduction: We previously demonstrated functionally significant structural plasticity within the central olfactory networks, in association with improved olfaction after surgical treatment of chronic rhinosinusitis (CRS). In order to confirm and expand on these findings, the primary aim of this study was to determine whether these same regions undergo functionally significant structural plasticity following functional septorhinoplasty (fSRP), in patients with non-CRS olfactory dysfunction (OD) of mixed cause. fSRP has previously been shown to improve olfactory function, and the secondary aim of this study was to provide initial insights into the mechanism by which fSRP affects olfaction.Methods: We performed a pilot prospective, multimodal neuroimaging study in 20 participants undergoing fSRP, including patients with non-CRS OD of mixed cause, as well as normosmic surgical controls. Participants underwent psychophysical olfactory testing, assessment of nasal airway, structural and functional neuroimaging. This was performed pre- and postoperatively in patients, and preoperatively in controls.Results: There was a statistically and clinically significant improvement in mean psychophysical olfactory scores after surgery. This was associated with structural and functional plasticity within areas of the central olfactory network (anterior cingulate, orbitofrontal cortex, insula, temporal pole). Improved psychophysical scores were significantly correlated with change in bilateral measures of nasal airflow, not measures of airflow symmetry, suggesting that improved overall airflow was more important than correction of septal deviation.Conclusion: This work highlights the importance of these neuroanatomical regions as potential structural correlates of olfactory function and dysfunction. Our results also provide initial insight into the mechanistic effects of fSRP on olfaction. Further work could investigate the utility of these regions as personalised biomarkers of OD, as well as the role of fSRP in treating OD.


  • Psychophysical Testing in Chemosensory Disorders

    by Miriam Fahmy, Katherine Whitcroft

    Purpose of Review To provide an overview of psychophysical testing in olfaction and gustation. Recent Findings Subjective patient report correlates poorly with objective assessment of olfaction and gustation. It is therefore important that clinicians and researchers perform psychophysical testing during chemosensory assessment. There are several validated psychophysical tests of olfaction and gustation, with ongoing developments accelerated by the COVID-19 pandemic. These tests have been culturally and linguistically adapted globally. Screening tests have been developed with careful consideration to distinguish normosmics from those with olfactory dysfunction. Summary Validated chemosensory tools are available for use by the clinician to support screening, diagnosis, or monitoring. There are promising advances in self-assessment and screening that provide avenues for the development of a standardised pathway for identification and formal assessment of patients with smell and taste disorders.